ConjuGon Raises $3.3 Million

ConjuGon Inc., a Madison, Wis.-based drug company focused on the treatment of antibiotic resistant bacterial infections, has raised $3.3 million in VC funding. Rosetta Partners led the deal, and was joined by returning angel backer Wisconsin Investment Partners. www.conjugon.com